Cargando…
Cholangiocarcinoma: New Insights
Cholangiocarcinoma is a malignant neoplasm originating from biliary epithelial cells. The incidence and mortality of this cancer are rising in the world. Currently, cholangiocarcinoma is accepted as a stem cell disease with many risk factors. Diagnosis is relatively simple but therapy is extremely d...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373807/ https://www.ncbi.nlm.nih.gov/pubmed/28669153 http://dx.doi.org/10.22034/APJCP.2017.18.6.1469 |
_version_ | 1783395048037023744 |
---|---|
author | Goral, Vedat |
author_facet | Goral, Vedat |
author_sort | Goral, Vedat |
collection | PubMed |
description | Cholangiocarcinoma is a malignant neoplasm originating from biliary epithelial cells. The incidence and mortality of this cancer are rising in the world. Currently, cholangiocarcinoma is accepted as a stem cell disease with many risk factors. Diagnosis is relatively simple but therapy is extremely difficult. Surgery is the mainstay of treatment for early stage patients. Endobiliary approaches, chemotherapy and radiotherapy are other therapeutic approaches. |
format | Online Article Text |
id | pubmed-6373807 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | West Asia Organization for Cancer Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-63738072019-03-19 Cholangiocarcinoma: New Insights Goral, Vedat Asian Pac J Cancer Prev Mini-Review Cholangiocarcinoma is a malignant neoplasm originating from biliary epithelial cells. The incidence and mortality of this cancer are rising in the world. Currently, cholangiocarcinoma is accepted as a stem cell disease with many risk factors. Diagnosis is relatively simple but therapy is extremely difficult. Surgery is the mainstay of treatment for early stage patients. Endobiliary approaches, chemotherapy and radiotherapy are other therapeutic approaches. West Asia Organization for Cancer Prevention 2017 /pmc/articles/PMC6373807/ /pubmed/28669153 http://dx.doi.org/10.22034/APJCP.2017.18.6.1469 Text en Copyright: © Asian Pacific Journal of Cancer Prevention http://creativecommons.org/licenses/BY-SA/4.0 This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License |
spellingShingle | Mini-Review Goral, Vedat Cholangiocarcinoma: New Insights |
title | Cholangiocarcinoma: New Insights |
title_full | Cholangiocarcinoma: New Insights |
title_fullStr | Cholangiocarcinoma: New Insights |
title_full_unstemmed | Cholangiocarcinoma: New Insights |
title_short | Cholangiocarcinoma: New Insights |
title_sort | cholangiocarcinoma: new insights |
topic | Mini-Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373807/ https://www.ncbi.nlm.nih.gov/pubmed/28669153 http://dx.doi.org/10.22034/APJCP.2017.18.6.1469 |
work_keys_str_mv | AT goralvedat cholangiocarcinomanewinsights |